Chordate Medical Holding AB (publ)

DB:K1Z0 Stock Report

Market Cap: €1.6m

Chordate Medical Holding Management

Management criteria checks 3/4

Chordate Medical Holding's CEO is Anders Weilandt, appointed in Jun 2017, has a tenure of 7.42 years. directly owns 0.82% of the company’s shares, worth €13.13K. The average tenure of the management team and the board of directors is 7.9 years and 7.6 years respectively.

Key information

Anders Weilandt

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure7.4yrs
CEO ownership0.8%
Management average tenure7.9yrs
Board average tenure7.6yrs

Recent management updates

Recent updates

CEO

Anders Weilandt (63 yo)

7.4yrs

Tenure

Mr. Anders Weilandt served as Director at Neola Medical AB (formerly known as GPX Medical AB (publ)) since May 2022 until 2024. Mr. Weilandt serves as the Chief Executive Officer at Chordate Medical Holdin...

Leadership Team

NamePositionTenureCompensationOwnership
Anders Weilandt
CEO & MD7.4yrsno data0.82%
€ 13.1k
Niklas Lindecrantz
Chief Financial Officer7.1yrsno data0.036%
€ 575.8
Jan Lindberg
CTO and Head of R&D12.8yrsno data0.010%
€ 162.4
Jan Hermansson
Chief Scientific Officer and Clinical Research & Medical Directorno datano data0.31%
€ 4.9k
Helena Thedius
Sales & Marketing Manager8.4yrsno datano data

7.9yrs

Average Tenure

63yo

Average Age

Experienced Management: K1Z0's management team is seasoned and experienced (7.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Tommy Hedberg
Independent Director10.4yrsSEK 100.00k2.54%
€ 40.8k
Gunilla Lundmark
Independent Director7.6yrsSEK 100.00kno data
Henrik Rammer
Independent Chairman10yrsSEK 180.00k1.36%
€ 21.9k
Caroline Brandberg
Independent Director3.1yrsSEK 100.00k5.96%
€ 95.8k
Otto Skolling
Vice Chairman1.5yrsSEK 140.00kno data

7.6yrs

Average Tenure

61yo

Average Age

Experienced Board: K1Z0's board of directors are considered experienced (7.6 years average tenure).